Phase 1 Start
ZLAB: Phase 1 Start: A Phase 1, Randomized, Open-label, Parallel-group Study to Evaluate the Pharmacokinetics, Safety and
September 3, 2026. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 3, 2026
- Company
- Zai Lab Ltd (ZLAB)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 1 Start~month
Phase 1 Start: A Phase 1, Randomized, Open-label, Parallel-group Study to Evaluate the Pharmacokinetics, Safety and
- Company
- Zai Lab Ltd (ZLAB)
- Indication
- Healthy Volunteers